26 stories found
Oscar Health (OSCR) experienced a stock decline despite reporting record profits and increasing its guidance. The article explores the potential reasons behind this unexpected market reaction to positive financial news from the health insurance company.
Several companies, including Fiserv, ConocoPhillips, and WPP, have released their Q2 2026 earnings reports and updated their financial outlooks. While some, like ConocoPhillips, beat estimates, others, like Fiserv, cut their 2026 outlook.
Oscar Health's stock has reached a new 52-week high, even as the company experienced $35.7 million in insider selling.
Oscar Health, a health insurance company, has received an upgrade from Barclays, citing valuation as the primary reason for the positive adjustment.
Oscar Health, Inc. conducted its earnings call for the first quarter of 2026, presenting its financial results and operational highlights.
Oscar Health (OSCR) stock experienced a 12.88% surge attributed to an increase in Medicare reimbursement rates.
Jim Cramer advised investors to retain their CoreWeave stock, indicating a positive long-term outlook for the company.
Oscar Health's CEO is confident the company will achieve profitability by 2026, outlining the strategies he believes will drive this financial turnaround.
Several companies, including Oscar Health, Optimum Communications, and Ormat Technologies, have released highlights from their second-quarter earnings calls. These reports provide updates on their financial performance and business operations for the recent quarter.
Insurer Oscar Health announced a substantial $361 million profit in the second quarter, bringing its net income for the first half of the year to over $1 billion, as medical costs for Obamacare members decreased.
An analysis explores whether Oscar Health, Inc. (OSCR) is currently a favorable stock for investment.
Wall Street analysts have issued new ratings, downgrading Nike while upgrading Oscar Health in their latest top analyst calls.
Several companies, including Root, Adient, TaskUs, and Maximus, have released their earnings call transcripts or summaries for the first or second quarter of 2026. These reports provide financial updates and insights into their recent performance.
The earnings transcript for Oscar Health (OSCR) for the first quarter of 2026 has been made available, providing insights into the company's financial results.
Oscar Health stock saw a rise following a significant insider purchase of nearly $12 million by its CEO, signaling executive confidence in the company.
An analysis is being conducted to determine if Oscar Health, Inc. (OSCR) is currently a favorable stock for investors to buy.
The Longleaf Partners Small-Cap Fund has seen positive returns from its investment in Oscar Health (OSCR), indicating a successful portfolio decision.
Second-quarter earnings reports have elicited varied responses in the stock market, with some companies like Hertz and Warner Bros Discovery seeing rallies after beating expectations, while others such as Datadog and Western Digital experienced significant declines despite strong earnings. This indicates a selective investor sentiment, separating perceived winners from losers in the ad-tech and software sectors.
Oscar Health's stock has seen a significant increase, rising by 100%, drawing attention from Wall Street analysts.
Barclays has upgraded Oscar Health stock, providing an analysis of the reasons behind this positive outlook for the healthcare company.
Oscar Health received an upgrade from Wells Fargo, with analysts citing tailwinds from the Affordable Care Act (Obamacare) as a key factor for the positive outlook.
Several companies, including ATN International, EVERTEC, Montrose Environmental, Phibro Animal, UGI, and TKO, have released their latest quarterly financial results. While some companies reported earnings that beat analyst expectations, others missed revenue or EPS forecasts.
Oscar Health has introduced a new consumer marketplace that offers insurance products beyond its own offerings.
Oscar Health's CEO has reportedly made a significant $12 million investment, interpreted as a strong vote of confidence in the company's future.
Raymond James has upgraded Oscar Health, Inc. (OSCR), while UBS has lowered its price target for the company, reflecting differing analyst perspectives.